The Merck Pill Bump and Why Extreme Selling Will Continue for Tech It's the second day of October trading, and I have the perfect game plan to get us through the week — it benefits from the news bomb about Merck's new antiviral pill for COVID-19. And it's already affecting other areas on the stock market, especially travel stocks... October is going to be all about playing the reopening names as Merck's announcement boosts investor sentiment on our recovering economy. But I also expect some extreme selling in technology to continue throughout this month, and for oil to make new highs. Luckily, on Tuesday I'm releasing nine — yes, nine — new trades that I put together that should allow us to profit in October no matter what the stock market conditions become… Get My October Gameplan Here Jeff Z Jeff Zananiri spent over two decades on Wall Street learning how the best made consistent money in the market.  New Trade Incoming! Get Ready to SWARM Brand-new picks are coming that are unlike any ordinary trades. Some may even call them extraordinary! Why? Because these special trades tap into "The Most Powerful Market Force in History." Because these trades are so special, I'm prepared to open a LIVE Trade Room this Tuesday, Oct. 5, to walk you through these incredible profiting opportunities. The catch? There isn't one. Just be prepared to show up Tuesday morning, ready to trade! Access the Next Trades Here! The Top Indexes for October — and Why You Must Dump Robinhood NOW October 1, 2021 Guys, we're finally entering a new trading month — which is historically the most volatile and bearish month on Wall Street. Continue Reading How to Profit From the Natural Gas Shortage and Europe's Energy Crisis October 2, 2021 Unless you live under a rock, then you know we've seen strong directional momentum from natural gas stocks lately. I touched on that earlier this week... Continue Reading Disclaimer: The material in this document is for informational purposes based on our proprietary research. It is not an offering, specific recommendation, or a solicitation of an offer to buy or sell any securities mentioned or discussed herein.  Any performance results discussed herein represent past performance, are not a guarantee of future performance, and are not indicative of any specific investment.  Due to the timing of information presented, any investment performance reflected within this document may be adjusted after the publication and distribution of this material. There can be no assurance that the future performance of any specific investment, investment strategy, or product made reference to directly or indirectly in this communication will be profitable, be equal to any corresponding indicated historical performance levels or be suitable for your portfolio. Any investment results set forth in this document are not net of expenses and execution costs, nor do they account for other relevant trading or investment fees. Please visit wealthpress.com/terms for our full Terms and Conditions.

WealthPress LLC | 7751 Belfort Parkway | Suite 120 | Jacksonville, FL 32556 | United States
Unsubscribe from future marketing messages from WealthPress LLC